Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Other Operating Expenses (2016 - 2022)

Historic Other Operating Expenses for Lipocine (LPCN) over the last 7 years, with Q2 2022 value amounting to $250000.0.

  • Lipocine's Other Operating Expenses rose 10625.0% to $250000.0 in Q2 2022 from the same period last year, while for Mar 2023 it was $250000.0, marking a year-over-year increase of 10625.0%. This contributed to the annual value of $250000.0 for FY2022, which is 10625.0% up from last year.
  • Latest data reveals that Lipocine reported Other Operating Expenses of $250000.0 as of Q2 2022, which was up 10625.0% from -$4.0 million recorded in Q2 2021.
  • In the past 5 years, Lipocine's Other Operating Expenses ranged from a high of $250000.0 in Q2 2022 and a low of -$4.0 million during Q2 2021